7.37
Tevogen Bio Holdings Inc stock is traded at $7.37, with a volume of 12,927.
It is down -0.54% in the last 24 hours and up +65.25% over the past month.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.
See More
Previous Close:
$7.41
Open:
$7.45
24h Volume:
12,927
Relative Volume:
0.44
Market Cap:
$30.86M
Revenue:
-
Net Income/Loss:
$-26.28M
P/E Ratio:
-1.7183
EPS:
-4.2891
Net Cash Flow:
$-12.39M
1W Performance:
+13.56%
1M Performance:
+65.25%
6M Performance:
-71.92%
1Y Performance:
-86.09%
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Name
Tevogen Bio Holdings Inc
Sector
Industry
Phone
646-807-8832
Address
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TVGN
Tevogen Bio Holdings Inc
|
7.37 | 30.86M | 0 | -26.28M | -12.39M | -4.2891 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-26 | Downgrade | D. Boral Capital | Buy → Hold |
| Mar-04-25 | Initiated | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Stock (TVGN) Latest News
Tevogen (TVGN) Soars 11% as Firm Gears Up for AI Training Commercialization - Insider Monkey
5 Stocks Exploding in a Bleeding Market - Insider Monkey
Tevogen Bio Holdings Inc. 2025 Annual Report: Executive Compensation, Corporate Governance, Audit Committee, and Key Filings - Minichart
TVGN Technical Analysis | Trend, Signals & Chart Patterns | TEVOGEN BIO HOLDINGS INC (NASDAQ:TVGN) - ChartMill
Tevogen Bio (NASDAQ: TVGN) adds governance, pay and related-party details - Stock Titan
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal - markets.businessinsider.com
Tevogen’s drug-targeting AI improves precision, starts commercial prep - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
TVGN Price Today: Tevogen Bio Holdings Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Tevogen files to sell 30.73M shares of common stock for holders - MSN
Tevogen Bio Holdings Inc. Receives Nasdaq Delisting Notice – Form 8-K Filing April 2026 - Minichart
Tevogen Bio receives Nasdaq notice for non-compliance with listing requirements - Investing.com
Tevogen Bio Faces Nasdaq Market Value Compliance Challenges - TipRanks
Tevogen Bio Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Tevogen Bio (NASDAQ: TVGN) warned on Nasdaq $50M, $15M value tests - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Is Tevogen (TVGN) stock worth watching (Smart Money Active) 2026-04-20Profit Surge - Cổng thông tin điện tử tỉnh Lào Cai
Form 10-KAnnual report [Section 13 and 15(d), not S-K Item 405] - ADVFN
Tevogen Bio Holdings Inc. (TVGNW) - Minichart
Aug Outlook: What is Tevogen Bio Holdings Incs valuation compared to sectorPortfolio Update Summary & Long-Term Growth Stock Strategies - baoquankhu1.vn
Is Tevogen (TVGN) Stock Good for Beginners | Price at $5.74, Up 0.17%Community Momentum Stocks - Newser
Forecast Cut: Is Tevogen Bio Holdings Inc stock good for income investors2026 PreEarnings & Expert Approved Trade Ideas - baoquankhu1.vn
Tevogen Bio Holdings (TVGN) price target increased by 1,900.00% to 102.00 - MSN
Is Tevogen (TVGN) Stock Expanding | Price at $5.53, Down 5.63%Certified Trade Ideas - Newser
Is Tevogen (TVGNW) Stock showing reversal signs | Price at $0.03, Up 15.19%Most Discussed Stocks - Newser
Sentiment Watch: What is Tevogen Bio Holdings Incs valuation compared to sector2026 Opening Moves & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Retail Trends: Is Tevogen Bio Holdings Inc Equity Warrant in accumulation or distribution phase2026 Institutional Moves & Low Risk Entry Point Tips - baoquankhu1.vn
Quarterly Risk: Whats the outlook for Tevogen Bio Holdings Incs sector2026 Pullback Review & Weekly High Return Stock Forecasts - baoquankhu1.vn
Loss Report: Is VCTR a potential multi baggerDollar Strength & Daily Stock Trend Reports - baoquankhu1.vn
Is Tevogen (TVGNW) Stock Breaking Out | Price at $0.03, Down 5.80%Undervalued Stocks - Xã Vĩnh Công
TVGNW Stock Analysis: Tevogen Bio Holdings Inc. Warrant holds steady at 0.03 in session review - Newser
TVGN Should I Buy - Intellectia AI
Buyout Rumor: Should you avoid Tevogen Bio Holdings Inc stock right now2026 Retail & Daily Growth Stock Tips - baoquankhu1.vn
Tevogen Bio (NASDAQ: TVGN) maps T-cell therapy and Long COVID push - Stock Titan
Tevogen Bio Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aug Sectors: Is Tevogen Bio Holdings Inc Equity Warrant undervalued by DCF analysis2026 Action & Long Hold Capital Preservation Tips - baoquankhu1.vn
Tevogen Bio Holdings Inc.Common Stock (NQ: TVGN - FinancialContent
Aug Macro: Can Tevogen Bio Holdings Inc Equity Warrant maintain its current growth rate2026 Closing Moves & Daily Oversold Bounce Ideas - baoquankhu1.vn
Volatility Watch: Is Tevogen Bio Holdings Inc stock a good pick for beginners2026 Trade Ideas & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Loss Report: Is Tevogen Bio Holdings Inc Equity Warrant stock heavily shortedMarket Trend Summary & Reliable Breakout Forecasts - baoquankhu1.vn
Tevogen Bio Regains Nasdaq Compliance After Reverse Split - The Globe and Mail
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth - Bitget
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and ... - Bluefield Daily Telegraph
Tevogen Bio Holdings Inc. Files Form 8-K on NASDAQ: Company Details and Key Information for March 2026 - Minichart
Tevogen Regains Compliance With Nasdaq Minimum Bid Price Requirement - 富途牛牛
Tevogen Bio regains Nasdaq compliance following reverse stock split By Investing.com - Investing.com India
Tevogen Bio regains Nasdaq compliance following reverse stock split - Investing.com
Tevogen Bio Holdings regains Nasdaq bid-price compliance after 1-for-50 reverse split - TradingView
Nasdaq restores TVGN listing after 1-for-50 reverse split (TVGN) - Stock Titan
Tevogen Bio (TVGN) restores Nasdaq bid-price compliance after 1-for-50 reverse split - Stock Titan
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement - Bitget
Tevogen Bio Holdings Inc Stock (TVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tevogen Bio Holdings Inc Stock (TVGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Flomenberg Neal | See Remarks |
Mar 13 '26 |
Sale |
6.40 |
501 |
3,206 |
76,940 |
| Flomenberg Neal | See Remarks |
Mar 10 '26 |
Sale |
7.75 |
19 |
147 |
77,893 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):